Revenue Decline, Continued Operating Loss, Treasury Share Retirement, Defense Backlog of 199 Billion Won

Consolidated revenue 15.8 billion won, down 8% YoY (Q1 2026)
Consolidated operating loss 1.14 billion won (vs loss of 0.85 billion won in Q1 2025, loss widened)
Separate revenue 7.65 billion won, down 16% YoY; operating loss 0.9 billion won (improved from loss of 1.41 billion won)
Retired 598,850 treasury shares via profit reserve cancellation, positive shareholder return
Debt ratio increased to 100.7% from 93.9% at year-end 2025 (deteriorating financial health)
Defense order backlog of 199 billion won, securing future revenue
R&D expense of 1.61 billion won (21% of revenue), maintaining technological competitiveness
Pending litigation for damages of 0.55 billion won, outcome uncertain
Guarantees provided to related party Labtron of 3.06 billion won

ADVERTISEMENT (250px+)